Saniona AB (FRA:30S) ROE % Adjusted to Book Value: -9.01% (As of Mar. 2026)


FRA:30S Saniona AB FRA:30S
68 GF Score
Price €1.15
GF Value €2.36
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Saniona AB ROE % Adjusted to Book Value?

Saniona AB FRA:30S -0.52% 68 ROE % Adjusted to Book Value is -9.01% as of Mar. 2026. GuruFocus rates FRA:30S with a GF Score™ of 68/100 and a GF Value™ of €2.36 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Saniona AB's ROE % for the quarter that ended in Mar. 2026 was -30.09%. Saniona AB's PB Ratio for the quarter that ended in Mar. 2026 was 3.34. Saniona AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -9.01%.

Saniona AB ROE % Adjusted to Book Value Related Terms

Saniona AB ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Saniona AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Saniona AB ROE % Adjusted to Book Value Chart

Saniona AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -42.89 -35.52 0.00 46.24 14.71

Saniona AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.16 -7.52 108.72 -5.59 -9.01

FRA:30S vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Saniona AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Saniona AB ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Saniona AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Saniona AB's ROE % Adjusted to Book Value falls into.


FRA:30S
68GF Score
Saniona AB FRA:30S
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Saniona AB ROE % Adjusted to Book Value Calculation

Saniona AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=66.63% / 4.53
=14.71%

Saniona AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-30.09% / 3.34
=-9.01%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -9.01% mean?
Saniona AB (FRA:30S) has a ROE % Adjusted to Book Value of -9.01% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Saniona AB and its competitors.
Is Saniona AB's ROE % Adjusted to Book Value too high?
Saniona AB's current ROE % Adjusted to Book Value is -9.01%. Overall, Saniona AB has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Saniona AB's ROE % Adjusted to Book Value compare to VRTX and REGN?
Saniona AB's ROE % Adjusted to Book Value of -9.01% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Saniona AB and its competitors. Saniona AB's current ROE % Adjusted to Book Value is -9.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saniona AB stock overvalued right now?
Based on GuruFocus' analysis, Saniona AB (FRA:30S) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.36, compared to a current price of €1.15 — trading 51.4% below its estimated fair value. The current ROE % Adjusted to Book Value is -9.01%. Saniona AB's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Saniona AB (FRA:30S), the current ROE % Adjusted to Book Value is -9.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Saniona AB (FRA:30S) Overvalued in 2026?

Based on GuruFocus' analysis, Saniona AB stock appears to be undervalued. The current stock price of €1.15 is trading 51.4% below its estimated GF Value™ of €2.36. GuruFocus considers Saniona AB to be Significantly Undervalued.

Key valuation signals for FRA:30S:

  • ROE % Adjusted to Book Value: -9.01%
  • GF Value™: €2.36 vs. price of €1.15 (51.4% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the FRA:30S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Saniona AB Business Description

Address Murervangen 42, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
68GF Score

Get the complete analysis for FRA:30S

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.15
Price
€2.36
GF Value